Moteur de recherche d’entreprises européennes
Financement de l’UE (3 474 343 €) : Structuration photolithographique sans précédent de nouveaux matériaux poly(acides aminés) sensibles à la lumière – un changement de paradigme dans la fourniture … Hor03/11/2023 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Structuration photolithographique sans précédent de nouveaux matériaux poly(acides aminés) sensibles à la lumière – un changement de paradigme dans la fourniture de dispositifs biocompatibles
Photolitography, which produces geometrical structures through light-induced polymerisation of monomers with high accuracy, precision and spatial resolution, was a key innovation enabler in the drive for high-performance miniature electronics, which had an unprecedented impact on every aspect of our modern life. Geometrically well-defined microstructures could also be a game changer in the medical device industry, especially in the development of implantable devices with better tissue compatibility, as well as in the discovery of new drugs and treatments. Current gold standard materials and biomaterial extrusion processing cannot generate the structural resolution to kick-start this new era. The groundbreaking approach of POLINA is to combine a radically new, light-sensitive poly(amino acid) material platform with established and emerging photolithographic patterning techniques to deliver a revolutionary technology that can be exploited for medical devices and next-generation green electronics. Exploring this uncharted territory will be possible through an ambitious multidisciplinary approach delivering breakthroughs in photopolymerisation of amino acids and their lithographic structuring for novel materials with unique biological properties. The high innovation potential of this technology to overcome current limitations will be demonstrated in three selected examples related to lung diseases, i.e., micropatterned cell surface models, spheroid arrays for lung disease modelling and drug testing as well as tracheal implants. Our intersectoral team of 5 academic groups and 2 SMEs brings together unique scientific expertise in photo and polymer chemistry, biomaterials science, lithographic processing, tissue engineering, clinical expertise and innovation management. Through POLINA we will pave the way to revolutionise bioprinting, for safer, smarter and affordable medical devices and in the long term a new approach in (bio)electronics.
| ACCELOPMENT SCHWEIZ AG | ? |
| 4Dcell | 523 125 € |
| Basque Center For Macromolecular Design And Engineering Polymat Fundazioa | 0,00 € |
| Centre National de la Recherche Scientifique CNRS | 478 210 € |
| Royal College of Surgeons in Ireland | 1 186 813 € |
| RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG | 381 988 € |
| Universidad del Pais Vasco/ Euskal Herriko Unibertsitatea | 364 750 € |
| Universidade de Aveiro | 539 458 € |
https://cordis.europa.eu/project/id/101129842
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : accelopment Schweiz AG, Zurich, Suisse.
Les visualisations de "ACCELOPMENT SCHWEIZ AG - Financement de l’UE (3 474 343 €) : Structuration photolithographique sans précédent de nouveaux matériaux poly(acides aminés) sensibles à la lumière – un changement de paradigme dans la fourniture …"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
